Literature DB >> 28959144

Active surveillance of prostate cancer: Current state of practice and utility of multiparametric magnetic resonance imaging.

Ridwan Alam1, H Ballentine Carter1, Jonathan I Epstein1, Jeffrey J Tosoian1.   

Abstract

Active surveillance (AS) is an alternative to immediate intervention in patients with very low- and low-risk prostate cancer. Ongoing reports from multiple AS programs have consistently demonstrated a very low rate of metastasis and prostate cancerspecific mortality in appropriately selected patients. Accordingly, AS has been adopted by major clinical organizations as a safe and effective management strategy. Clinical focus has now shifted to identifying the optimal approach to selecting and monitoring patients. Multiparametric magnetic resonance imaging (mpMRI) has emerged as one potentially helpful tool in the AS setting. The utility of mpMRI has been well demonstrated in the setting of screening and diagnosis, but its role in AS remains unclear. We summarize the published experience with AS and review pertinent, contemporary data on the use of mpMRI in the setting of AS.

Entities:  

Keywords:  Active surveillance; Multiparametric magnetic resonance imaging; Prostate cancer

Year:  2017        PMID: 28959144      PMCID: PMC5610357          DOI: 10.3909/riu0757a

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  51 in total

1.  Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population.

Authors:  Win Shun Lai; Jennifer B Gordetsky; John V Thomas; Jeffrey W Nix; Soroush Rais-Bahrami
Journal:  Cancer       Date:  2017-01-31       Impact factor: 6.860

2.  Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?

Authors:  Francesco Porpiglia; Francesco Cantiello; Stefano De Luca; Agostino De Pascale; Matteo Manfredi; Fabrizio Mele; Enrico Bollito; Stefano Cirillo; Rocco Damiano; Filippo Russo
Journal:  Int J Urol       Date:  2016-06-09       Impact factor: 3.369

3.  Reevaluating PSA Testing Rates in the PLCO Trial.

Authors:  Jonathan E Shoag; Sameer Mittal; Jim C Hu
Journal:  N Engl J Med       Date:  2016-05-05       Impact factor: 91.245

4.  Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Authors:  Richard Choo; Laurence Klotz; Cyril Danjoux; Gerard C Morton; Gerrit DeBoer; Ewa Szumacher; Neil Fleshner; Peter Bunting; George Hruby
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

5.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading.

Authors:  Adil Ouzzane; Philippe Puech; Laurent Lemaitre; Xavier Leroy; Pierre Nevoux; Nacim Betrouni; Georges-Pascal Haber; Arnauld Villers
Journal:  Urology       Date:  2011-08-16       Impact factor: 2.649

6.  Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment.

Authors:  Mark S Soloway; Cynthia T Soloway; Ahmed Eldefrawy; Kristell Acosta; Bruce Kava; Murugesan Manoharan
Journal:  Eur Urol       Date:  2010-08-20       Impact factor: 20.096

Review 7.  Active surveillance for prostate cancer: current evidence and contemporary state of practice.

Authors:  Jeffrey J Tosoian; H Ballentine Carter; Abbey Lepor; Stacy Loeb
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

8.  Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.

Authors:  Ely R Felker; Jason Wu; Shyam Natarajan; Daniel J Margolis; Steven S Raman; Jiaoti Huang; Fred Dorey; Leonard S Marks
Journal:  J Urol       Date:  2015-12-07       Impact factor: 7.450

9.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

10.  The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance.

Authors:  Chang Wook Jeong; Yong Hyun Park; Sung Ii Hwang; Sangchul Lee; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Hak Jong Lee; Sang Eun Lee
Journal:  Prostate Int       Date:  2014-12-30
View more
  1 in total

1.  Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study.

Authors:  Frank-Jan H Drost; Antti Rannikko; Riccardo Valdagni; Tom Pickles; Yoshiyuki Kakehi; Sebastiaan Remmers; Henk G van der Poel; Chris H Bangma; Monique J Roobol
Journal:  Transl Androl Urol       Date:  2018-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.